Cubist Systematic Strategies LLC boosted its stake in shares of Encompass Health Corp (AMEX:EHC) by 31.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 10,147 shares of the company’s stock after acquiring an additional 2,425 shares during the quarter. Cubist Systematic Strategies LLC’s holdings in Encompass Health were worth $687,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of EHC. Harvest Fund Management Co. Ltd acquired a new stake in shares of Encompass Health in the 2nd quarter valued at approximately $107,000. Point72 Asia Hong Kong Ltd acquired a new stake in shares of Encompass Health in the 1st quarter valued at approximately $142,000. Meeder Asset Management Inc. lifted its holdings in shares of Encompass Health by 97.0% in the 2nd quarter. Meeder Asset Management Inc. now owns 2,092 shares of the company’s stock valued at $142,000 after buying an additional 1,030 shares during the period. Mount Yale Investment Advisors LLC acquired a new stake in shares of Encompass Health in the 1st quarter valued at approximately $143,000. Finally, Ostrum Asset Management acquired a new stake in shares of Encompass Health in the 1st quarter valued at approximately $198,000. 93.18% of the stock is owned by institutional investors.

In related news, insider Cheryl B. Levy sold 28,955 shares of the firm’s stock in a transaction that occurred on Friday, August 3rd. The stock was sold at an average price of $78.00, for a total value of $2,258,490.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Andrew L. Price sold 9,457 shares of the firm’s stock in a transaction that occurred on Tuesday, August 14th. The shares were sold at an average price of $80.04, for a total value of $756,938.28. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

Several analysts have recently commented on the company. SunTrust Banks reissued a “buy” rating and issued a $82.00 price target on shares of Encompass Health in a report on Friday, July 20th. Piper Jaffray Companies raised Encompass Health from a “neutral” rating to an “overweight” rating in a report on Thursday, July 26th. Zacks Investment Research raised Encompass Health from a “hold” rating to a “buy” rating and set a $84.00 price target for the company in a report on Friday, July 27th. Mizuho reissued a “buy” rating and issued a $82.00 price target on shares of Encompass Health in a report on Thursday, July 26th. Finally, Credit Suisse Group raised their price target on Encompass Health from $66.00 to $80.00 and gave the company an “outperform” rating in a report on Thursday, July 26th. One analyst has rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $71.10.

AMEX EHC opened at $57.67 on Monday. Encompass Health Corp has a 1-year low of $40.86 and a 1-year high of $59.29. The company has a debt-to-equity ratio of 1.89, a quick ratio of 1.34 and a current ratio of 1.34.

Encompass Health (AMEX:EHC) last released its quarterly earnings data on Wednesday, July 25th. The company reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.83 by $0.16. Encompass Health had a return on equity of 23.56% and a net margin of 8.67%. The firm had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.03 billion. The firm’s revenue was up 10.5% compared to the same quarter last year. research analysts predict that Encompass Health Corp will post 2.72 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 15th. Investors of record on Monday, October 1st will be paid a $0.27 dividend. This is an increase from Encompass Health’s previous quarterly dividend of $0.25. This represents a $1.08 annualized dividend and a yield of 1.87%. The ex-dividend date of this dividend is Friday, September 28th.

Encompass Health Company Profile

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

Recommended Story: How is a Moving Average Calculated?

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corp (AMEX:EHC).

Institutional Ownership by Quarter for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.